1. Home
  2. KLAC vs ABT Comparison

KLAC vs ABT Comparison

Compare KLAC & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KLA Corporation

KLAC

KLA Corporation

N/A

Current Price

$169.81

Market Cap

186.0B

Sector

Technology

ML Signal

N/A

ABT

Abbott Laboratories

N/A

Current Price

$108.99

Market Cap

152.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KLAC
ABT
Founded
1975
1888
Country
United States
United States
Employees
N/A
N/A
Industry
Electronic Components
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
186.0B
152.9B
IPO Year
1994
2006

Fundamental Metrics

Financial Performance
Metric
KLAC
ABT
Price
$169.81
$108.99
Analyst Decision
Buy
Strong Buy
Analyst Count
19
20
Target Price
$1,651.00
$130.90
AVG Volume (30 Days)
8.0M
5.3M
Earning Date
04-29-2026
04-16-2026
Dividend Yield
0.42%
2.76%
EPS Growth
N/A
N/A
EPS
3.66
0.61
Revenue
N/A
$44,328,000,000.00
Revenue This Year
$12.45
$10.75
Revenue Next Year
$22.33
$8.10
P/E Ratio
$48.06
$180.90
Revenue Growth
N/A
5.67
52 Week Low
$169.80
$81.97
52 Week High
$2,431.29
$137.49

Technical Indicators

Market Signals
Indicator
KLAC
ABT
Relative Strength Index (RSI) 28.06 49.95
Support Level N/A $105.27
Resistance Level $214.80 $110.95
Average True Range (ATR) 6.66 2.20
MACD 9.57 -0.98
Stochastic Oscillator 3.47 2.67

Price Performance

Historical Comparison
KLAC
ABT

About KLAC KLA Corporation

KLA is one of the largest semiconductor wafer fabrication equipment, or WFE, manufacturers in the world. It specializes in the market segment of semiconductor process control, wherein machines inspect semiconductor wafers during research and development and manufacturing for defects and verify precise measurements. In this section of the market, KLA holds a majority share. It also has a small exposure to the etch and deposition segments of the WFE market. It counts as top customers the largest chipmakers in the world, including TSMC and Samsung.

About ABT Abbott Laboratories

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.

Share on Social Networks: